TY - JOUR
T1 - Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus
AU - Jordan, V. C.
AU - Gosden, B.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1982/8
Y1 - 1982/8
N2 - The estrogenic and antiestrogenic properties of tamoxifen and trioxifene were compared with their phenolic derivatives (ICI 77949 and LY 126412, respectively) without the alkylaminoethoxy side-chain. Trioxifene was a more potent antiestrogen than tamoxifen in immature rat uterine weight tests and both compounds were partial estrogen agonists. Removal of the side-chain from tamoxifen to produce ICI 77949 converted the compound from a partial estrogen agonist to a full estrogen agonist. Tamoxifen, trioxifene and ICI 77949, produced an estradiol-like increase in uterine progesterone receptor concentrations (as determined by sucrose density gradient analysis) and a dose-related, estradiol-like, increase in the size and shape of uterine luminal epithelial cells. In contrast, removal of the side-chain from trioxifene to produce LY 126412 converted the compound from a partial estrogen agonist, with antiestrogenic properties, to one with a very low affinity for the estrogen receptor and no biological activity in vivo at the daily doses tested (1-64 μg). This was established by uterine wet weight tests, histological examination of luminal epithelial cells and determination of progesterone receptor concentrations. The alkylaminoethoxy side-chain is not only necessary for the antiestrogenic properties of both tamoxifen and trioxifene but also essential for the effective estrogen receptor binding and pharmacological actions of trioxifene.
AB - The estrogenic and antiestrogenic properties of tamoxifen and trioxifene were compared with their phenolic derivatives (ICI 77949 and LY 126412, respectively) without the alkylaminoethoxy side-chain. Trioxifene was a more potent antiestrogen than tamoxifen in immature rat uterine weight tests and both compounds were partial estrogen agonists. Removal of the side-chain from tamoxifen to produce ICI 77949 converted the compound from a partial estrogen agonist to a full estrogen agonist. Tamoxifen, trioxifene and ICI 77949, produced an estradiol-like increase in uterine progesterone receptor concentrations (as determined by sucrose density gradient analysis) and a dose-related, estradiol-like, increase in the size and shape of uterine luminal epithelial cells. In contrast, removal of the side-chain from trioxifene to produce LY 126412 converted the compound from a partial estrogen agonist, with antiestrogenic properties, to one with a very low affinity for the estrogen receptor and no biological activity in vivo at the daily doses tested (1-64 μg). This was established by uterine wet weight tests, histological examination of luminal epithelial cells and determination of progesterone receptor concentrations. The alkylaminoethoxy side-chain is not only necessary for the antiestrogenic properties of both tamoxifen and trioxifene but also essential for the effective estrogen receptor binding and pharmacological actions of trioxifene.
KW - estrogen receptor
KW - progesterone receptor
KW - uterine histology
UR - http://www.scopus.com/inward/record.url?scp=0019941226&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019941226&partnerID=8YFLogxK
U2 - 10.1016/0303-7207(82)90095-8
DO - 10.1016/0303-7207(82)90095-8
M3 - Article
C2 - 7128917
AN - SCOPUS:0019941226
SN - 0303-7207
VL - 27
SP - 291
EP - 306
JO - Molecular and cellular endocrinology
JF - Molecular and cellular endocrinology
IS - 3
ER -